首页> 外国专利> COMPOSITIONS AND METHODS TARGETING GLUTAMINE AND ITS METABOLISM FOR DIAGNOSING AND TREATING CANCER AND THERAPY-ASSOCIATED SIDE EFFECTS

COMPOSITIONS AND METHODS TARGETING GLUTAMINE AND ITS METABOLISM FOR DIAGNOSING AND TREATING CANCER AND THERAPY-ASSOCIATED SIDE EFFECTS

机译:靶向谷氨酰胺的组合物和方法及其代谢用于诊断和治疗癌症和治疗相关副作用

摘要

The present disclosure provides compositions, markers, and methods for diagnosing and treating cancer and other conditions. The method includes administering at least one androgen deprivation therapy to the subject; and administering a therapeutically effective amount of at least one inhibitor to the subject, wherein the at least one inhibitor is selected from the group including: at least one macropinocytosis inhibitor, at least one glutamine metabolism inhibitor, at least one glutaminase inhibitor, and any combinations thereof.
机译:本公开提供了用于诊断和治疗癌症和其他条件的组合物,标记和方法。 该方法包括向受试者施用至少一种雄激素剥夺疗法; 并对受试者施用治疗有效量的至少一个抑制剂,其中至少一种抑制剂选自包括:至少一种大血细胞增多抑制剂,至少一种谷氨酰胺代谢抑制剂,至少一种谷氨酰胺酶抑制剂和任何组合 它。

著录项

  • 公开/公告号US2021260057A1

    专利类型

  • 公开/公告日2021-08-26

    原文格式PDF

  • 申请/专利权人 CEDARS-SINAI MEDICAL CENTER;

    申请/专利号US201917257531

  • 发明设计人 NEIL BHOWMICK;RAJEEV MISHRA;BETHANY SMITH;

    申请日2019-07-12

  • 分类号A61K31/501;A61K31/198;A61K45/06;A61K31/433;G01N33/68;

  • 国家 US

  • 入库时间 2022-08-24 20:48:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号